Common variants in the ATM, BRCA1, BRCA2, CHEK2 and TP53 cancer susceptibility genes are unlikely to increase breast cancer risk

IntroductionCertain rare, familial mutations in the ATM, BRCA1, BRCA2, CHEK2 or TP53 genes increase susceptibility to breast cancer but it has not, until now, been clear whether common polymorphic variants in the same genes also increase risk.MethodsWe have attempted a comprehensive, single nucleotide polymorphism (SNP)- and haplotype-tagging association study on each of these five genes in up to 4,474 breast cancer cases from the British, East Anglian SEARCH study and 4,560 controls from the EPIC-Norfolk study, using a two-stage study design. Nine tag SNPs were genotyped in ATM, together with five in BRCA1, sixteen in BRCA2, ten in CHEK2 and five in TP53, with the aim of tagging all other known, common variants. SNPs generating the common amino acid substitutions were specifically forced into the tagging set for each gene.ResultsNo significant breast cancer associations were detected with any individual or combination of tag SNPs.ConclusionIt is unlikely that there are any other common variants in these genes conferring measurably increased risks of breast cancer in our study population.

[1]  S. Chanock,et al.  The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer , 2006, Human mutation.

[2]  D. Altshuler,et al.  A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. , 2005, Cancer research.

[3]  Paul D.P. Pharoah,et al.  Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium. , 2007, Journal of the National Cancer Institute.

[4]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[5]  S. Seal,et al.  Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. , 1999, Journal of the National Cancer Institute.

[6]  Nazneen Rahman,et al.  CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. , 2004, American journal of human genetics.

[7]  Anglian Breast Cancer Study Group.  Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases , 2000 .

[8]  J. Palmgren,et al.  Linkage Disequilibrium Mapping of CHEK2: Common Variation and Breast Cancer Risk , 2006, PLoS medicine.

[9]  D. Altshuler,et al.  Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort. , 2004, Human molecular genetics.

[10]  M. Walter,et al.  Identification of target genes regulated by FOXC1 using nickel agarose-based chromatin enrichment. , 2004, Investigative ophthalmology & visual science.

[11]  R. W. Davis,et al.  Global analysis of ATM polymorphism reveals significant functional constraint. , 2001, American journal of human genetics.

[12]  J. Chang-Claude,et al.  A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability , 2000, Nature Genetics.

[13]  Nazneen Rahman,et al.  ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles , 2006, Nature Genetics.

[14]  Christopher A. Haiman,et al.  Choosing Haplotype-Tagging SNPS Based on Unphased Genotype Data Using a Preliminary Sample of Unrelated Subjects with an Example from the Multiethnic Cohort Study , 2003, Human Heredity.

[15]  N E Day,et al.  A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes , 2002, British Journal of Cancer.

[16]  D. Clayton,et al.  Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. , 1997, Human molecular genetics.

[17]  D. Hunter,et al.  Haplotype analysis of common variants in the BRCA1 gene and risk of sporadic breast cancer , 2004, Breast Cancer Research.

[18]  D. Hunter,et al.  No Association between BRCA2 N372H and Breast Cancer Risk , 2005, Cancer Epidemiology Biomarkers & Prevention.

[19]  C. Ulrich,et al.  Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  G. Giles,et al.  The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[21]  C. Cannings,et al.  Heterozygote excess is repeatedly observed in females at the BRCA2 locus N372H , 2004, Journal of Medical Genetics.